JPRN-UMIN000004881尚未招募未知
DPP-4(Dipeptidyl peptidase-4) inhibitor Sitagliptin Phosphate Hydrate study to the inhibition of extension atherosclerosis - Study of DPP-4 inhibitor for preventing artheriosclerosis
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Has a history of allergy to Sitagliptin Phosphate Hydrate 2.Has a history of severe ketosis, diabetic coma and type1 diabetes mellitus 3.Has a history of severe renal insufficiency (hemodialysis or peritoneal dialysis patients) 4.Has a history of severe infection, perioperative term and severe wound 5.Has a overt systemic disease (liver cirrhosis, thyroid gland disease and nephrotic syndrome and so on) 6.Is not appropriate in the investigators' opinion
研究者
相似试验
已完成
不适用
Effects of dipeptidyl peptidase-4 (DPP-4) inhibitor, alogliptin, on coronary atherosclerosis in patients with type 2 diabetes mellitusPatients with type 2 diabetes mellitus who were suspected as having ischemic heart diseaseJPRN-UMIN000015381Kanagawa PTCA Conference50
已完成
不适用
Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.JPRN-UMIN000007255Center for Cardiovascular Interventions,Chiba University Hospital128
已完成
不适用
The impact of dipeptidyl peptidase-4 inhibitor on coronary microvascular function in patients with type2 diabetes mellitusType 2 diabetic patients with stable angina pectoris who undergo percutaneous coronary interventionJPRN-UMIN000004390Cardiovascular Division, Hyogo College of Medicine40
尚未招募
不适用
Association between dipeptidyl peptidase-4 inhibitor and acute kidney injuryAdult with diabetes mellitusJPRN-UMIN000051147Kaetsu Hospital
进行中（未招募）
1 期
A study to investigate whether a drug called Januvia, that is licensed to lower blood glucose in diabetic patients, has an effect on psoriasis.EUCTR2012-005483-10-IEniversity College Dublin